Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?

Annals of Allergy, Asthma and Immunology

Volumn 104, Issue 3, 2010, Pages 211-214

  Lunn, Michael L ^a   Santos, Carah B ^a   Craig, Timothy J ^a  

^a Division of Pulmonary   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4 BINDING PROTEIN; DANAZOL;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; COMPLEMENT BLOOD LEVEL; COMPLEMENT COMPONENT C1S INHIBITOR DEFICIENCY; COMPLEMENT FACTOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME DEFICIENCY; EXTENDED FAMILY; FAMILY; FRANCE; GERMANY; HEALTH SURVEY; HUMAN; IMMUNOPROPHYLAXIS; INTERNET; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; NETHERLANDS; NORMAL HUMAN; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; QUESTIONNAIRE; SCREENING; STANDARDIZATION; UNITED KINGDOM; UNITED STATES;

ANGIOEDEMAS, HEREDITARY; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT C4; DANAZOL; DIAGNOSIS, DIFFERENTIAL; EUROPE; HUMANS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; UNITED STATES;

EID: 77649160177     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2009.12.004     Document Type: Article

References (16)

1. Bock S.C., Skriver K., Nielsen E., et al. Human C1 inhibitor: primary structure, cDNA, cloning, and chromosomal localization. Biochemistry 25 (1986) 4292-4301
2. Theriault A., Whaley K., McPhaden A.R., Boyd E., and Connor J.M. Regional assignment of the human C1-inhibitor gene to 11q11-q13.1. Human Genet 84 (1990) 477-479
3. Zuraw B.L., and Herschbach J. Detection of C1 inhibitor mutations in patients with hereditary angioedema. J Allergy Clin Immunol 105 (2000) 541-546
4. Bowen B., Hawk J.J., Sibunka S., et al. A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations. Clin Immunol 98 (2001) 157-163
5. Bork K., Barnstedt S., Koch P., and Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356 (2000) 213-217
6. Nzeako U.C., Frigas E., and Tremaine W.J. Hereditary angioedema: a broad review for clinicians. Arch Intern Med 161 (2001) 2417-2429
7. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 100 suppl 2 (2008) S30-S40
8. Farkas H., and Varga L. The Hungarian HAE experience. Transfusion Apheresis Sci 29 (2003) 229-233
9. Farkas H., Harmat G., Fay A., et al. Erythema marginatum preceding an acute edematous attack of hereditary angioneurotic oedema. Acta Derm Venereol 81 (2001) 376-377
10. Zingale L.C., Beltrami L., Zanichellia A., et al. Angioedema without urticaria: a large clinical survey. CMAJ 175 (2006) 1065-1070
11. Zuraw B.L., Sugimoto S., and Curd J.G. The value of rocket immunoelectropheresis for C4 activation in the evaluation of patients with angioedema or C1-inhibitor deficiency. J Allergy Clin Immunol 78 (1986) 1115-1120
12. Nielsen E.W., Johansen H.T., Holt J., and Mollness T.E. C1 inhibitor and diagnosis of hereditary angioedema in newborns. Pedatr Res 35 (1994) 184-187
13. Roach B., Kim Y., Jerome E., and Michael A.F. Influence of age and sex on serum complement components in children. Am J Dis Child 135 (1981) 918-920
14. Agostoni A., Aygören-Pürsün E., Binkley K.E., et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114 suppl (2004) S51-S131
15. Agenda, Proceedings, Recommendations and the Power Point Presentation From Comprehensive Care for Rare Blood Disorders; February 3-5 2006; organized by the Canadian Network of Rare Blood Disorder Organizations. Program and abstracts for the Fifth C1 Inhibitor Deficiency Workshop; Budapest; May 31 to June 3, 2007.
16. Tosi M. Molecular genetics of C1 inhibitor. Immunobiology 199 (1998) 358-365